These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15180709)

  • 1. Hepatitis C with normal liver enzymes: to treat or not to treat. Pro: most patients should be treated.
    Koff JM; Younossi Z
    Am J Gastroenterol; 2004 Jun; 99(6):972-3. PubMed ID: 15180709
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C with normal liver enzymes: to treat or not to treat. Con: most patients should not be treated.
    Reddy KR
    Am J Gastroenterol; 2004 Jun; 99(6):973-5. PubMed ID: 15180710
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C with normal liver enzymes: to treat or not to treat. A balancing view: a decision to be shared with patients.
    Shiffman ML
    Am J Gastroenterol; 2004 Jun; 99(6):975-6. PubMed ID: 15180711
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral therapy for chronic hepatitis C.
    Sievert W
    Aust Fam Physician; 2003 Oct; 32(10):826-32. PubMed ID: 14596080
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic hepatitis C and normal ALT: considerations for treatment.
    Bacon BR
    Am J Gastroenterol; 2004 Sep; 99(9):1706-7. PubMed ID: 15330906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT.
    Jacobson IM; Ahmed F; Russo MW; Lebovics E; Dieterich DT; Esposito SP; Bach N; Klion F; Tobias H; Antignano L; Brown RS; Gabbaizadeh D; Geders J; Levendoglu H
    Am J Gastroenterol; 2004 Sep; 99(9):1700-5. PubMed ID: 15330905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eliminating the gray zone. What can be done in normal ALT values?].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():75. PubMed ID: 15373059
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatitis C in Egypt, a iatrogenic epidemic].
    Vrolijk JM; Schalm SW
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2378. PubMed ID: 11129975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Due to normal transaminase values, no further treatment. Hepatitis C patient "suddenly" has liver cirrhosis].
    MMW Fortschr Med; 2004 May; 146(19):64. PubMed ID: 15357490
    [No Abstract]   [Full Text] [Related]  

  • 10. Can Peg-IFN alpha-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels?
    Dusheiko G; Danta M
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):130-1. PubMed ID: 16265150
    [No Abstract]   [Full Text] [Related]  

  • 11. Children with hepatitis C.
    Rao GS; Molleston JP
    Curr Gastroenterol Rep; 2005 Feb; 7(1):37-44. PubMed ID: 15701297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Maintenance" treatment for patients with cirrhosis related to hepatitis C.
    Gross JB
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):427-9. PubMed ID: 17445750
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic viral hepatitis].
    Serov VV; Aprosina ZG; Ignatova TM; Krel' PE; Sekamova SM; Tanashchuk EL; Il'iankova AA
    Vestn Ross Akad Med Nauk; 2003; (4):34-8. PubMed ID: 12741358
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined interferon-alfa-2b and ribavirin therapy in patients with recurrent chronic hepatitis c after liver transplantation].
    Lengyel G; Kóbori L; Fehérvári I; Nemes B; Görög D; Patonai A; Sárváry E; Varga M; Perner F; Fehér J
    Orv Hetil; 2003 Nov; 144(48):2367-70. PubMed ID: 14753031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic hepatitis C].
    Fehér J; Lengyel G
    Orv Hetil; 2004 May; 145(20):1065-7. PubMed ID: 15202329
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic hepatitis C. Chances of healing good as never before].
    MMW Fortschr Med; 2003 Oct; 145(42):61. PubMed ID: 14655449
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan.
    Yu ML; Dai CY; Lin ZY; Lee LP; Hou NJ; Hsieh MY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL
    Liver Int; 2006 Feb; 26(1):73-81. PubMed ID: 16420512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin].
    Fontaine H; Pol S
    Gastroenterol Clin Biol; 1999 Apr; 23(4):541-4. PubMed ID: 10416124
    [No Abstract]   [Full Text] [Related]  

  • 19. Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.
    Fabris P; Brown D; Tositti G; Bozzola L; Giordani MT; Bevilacqua P; de Lalla F; Webster GJ; Dusheiko G
    J Clin Virol; 2004 Mar; 29(3):160-6. PubMed ID: 14962784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.